EON CHUL HAN

Dr. EON CHUL HAN

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EHEON CHUL HAN
EON CHUL HAN
SRSeung-Bum Ryoo
Seung-Bum Ryoo
JPJi Won Park
Ji Won Park
JYJin Wook Yi
Jin Wook Yi
HOHeung-Kwon Oh
Heung-Kwon Oh
KPKyu Joo Park
Kyu Joo Park
The management of colorectal cancer in patients with liver cirrhosis requires a thorough understanding of both diseases. This study evaluated the effect of liver cirrhosis on oncologic and surgical outcomes and prognostic factors in colorectal cancer patients. Fifty-five consecutive colorectal cancer patients with liver cirrhosis underwent colorectal resection (LC group). Using a prospectively maintained database, these patients were matched 1:4 using propensity scoring with R programming language, package "MatchIt" and "optmatch" by sex, age, cancer location, and tumor stage with 220 patients without liver cirrhosis (non-LC group), resulting in 275 patients. The 5-year overall survival (OS) was significantly worse in the LC group than in the non-LC group (46.7% vs. 76.2% respectively, P < 0.001); however, the 5-year proportion of recurrence free (PRF) rates were similar (73.1% vs. 84.5% respectively, P = 0.094). On multivariate analysis of the LC group, tumor-node-metastasis (TNM) stage ≥III disease, venous invasion, and a model for end-stage liver disease plus serum sodium (MELD-Na) score >10 were prognostic factors for OS. However, the OS was not different between the LC group with MELD-Na score ≤10 and the non-LC group (5-year OS rate, TNM stage ≤II, 85.7 vs 89.5%, p = 0.356; TNM stage ≥III, 41.1 vs 66.2%, p = 0.061). Colorectal cancer patients with liver cirrhosis have poorer OS compared to those without liver cirrhosis; however, the PRF rates are similar. It might be due to the mortality from the liver, and surgical treatment should be actively considered for patients with MELD-Na score <10.

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
ECEun Kyung Choe
Eun Kyung Choe
KPKyu Joo Park
Kyu Joo Park
SRSeung-Bum Ryoo
Seung-Bum Ryoo
SMSang Hui Moon
Sang Hui Moon
HOHeung-Kwon Oh
Heung-Kwon Oh
EHEON CHUL HAN
EON CHUL HAN
Choe EK, et al. J Korean Med Sci. 2016 Oct;31(10):1571-1578. https://doi.org/10.3346/jkms.2016.31.10.1571

28 February 2025 in Annals of Coloproctology
Verified
Journal Article
Open access
KLKil Yong Lee
Kil Yong Lee
SLSoo Young Lee
Soo Young Lee
MCMiyoung Choi
Miyoung Choi
MKMoonjin Kim
Moonjin Kim
JKJi Hong Kim
Ji Hong Kim
TNthe Korean Enhanced Recovery After Surgery (ERAS) Committee within the Korean Society of Surgical Metabolism and Nutrition
the Korean Enhanced Recovery After Surgery (ERAS) Committee within the Korean Society of Surgical Metabolism and Nutrition
The Korean Enhanced Recovery After Surgery (ERAS) Committee within the Korean Society of Surgical Metabolism and Nutrition was established to develop ERAS guidelines tailored to the Korean context. This guideline focuses on creating the most current evidence-based practice guidelines for ERAS purposes, based on systematic reviews. All key questions targeted randomized controlled trials exclusively, and if fewer than 2 were available, studies employing propensity score matching were also included. Recommendations for each key question were marked with strength of recommendation and level of evidence following internal and external review processes by the committee.

30 April 2024 in Annals of Coloproctology
Verified
Journal Article
Open access
PDF file
TLTae-Gyun Lee
Tae-Gyun Lee
GSGil-Hyeon Song
Gil-Hyeon Song
HAHong-Min Ahn
Hong-Min Ahn
HOHeung-Kwon Oh
Heung-Kwon Oh
MBMoonkyoung Byun
Moonkyoung Byun
O(on behalf of the Public Relations Committee of the Korean Society of Coloproctology (KSCP)
on behalf of the Public Relations Committee of the Korean Society of Coloproctology (KSCP)
Purpose: The Korean Society of Coloproctology has been conducting Colorectal Cancer Awareness Campaign, also known as the Gold Ribbon Campaign, every September since 2007. The 2022 campaign was held through a metaverse platform targeting the younger age group under the slogan of raising awareness of early-onset colorectal cancer (CRC). This study aimed to analyze the impact of the 2022 campaign on a metaverse platform.Methods: Anonymized survey data were collected from participants in the metaverse campaign from September 1 to 15, 2022. The satisfaction score of the participants was evaluated by sex, age group, and previous campaign participation status.Results: During the campaign, 2,770 people visited the metaverse. Among them, 455 people participated in the survey (response rate, 16.4%). Approximately 95% of the participants reported being satisfied with the information provided by the campaign, understood the necessity of undergoing screening for and prevention of early-onset CRC, and were familiar with the structure of the metaverse. The satisfaction score for campaign information tended to decrease as the participants’ age increased. When the participants’ overall level of satisfaction with the metaverse platform was assessed, teenagers scored particularly lower than the other age groups. The satisfaction scores for CRC information provided in the metaverse, as well as the scores for recognizing the seriousness and necessity of screening for early-onset CRC, indicated a high positive tendency (P<0.001).Conclusion: Most of the 2022 Gold Ribbon Campaign participants were satisfied with the metaverse platform. Medical society should pay attention to increasing participation in and satisfaction with future public campaigns.

1 January 2022 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
KLKil Yong Lee
Kil Yong Lee
JLJumyung Lee
Jumyung Lee
EHEON CHUL HAN
EON CHUL HAN
YKYoon-Hye Kwon
Yoon-Hye Kwon
SRSeung-Bum Ryoo
Seung-Bum Ryoo
KPKyu Joo Park
Kyu Joo Park
Lee KY, et al. Ann Surg Treat Res. 2022 Mar;102(3):167-175. https://doi.org/10.4174/astr.2022.102.3.167

1 January 2020 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
NSNari Shin
Nari Shin
EHEON CHUL HAN
EON CHUL HAN
SWSungho Won
Sungho Won
SRSeung-Bum Ryoo
Seung-Bum Ryoo
ECEun Kyung Choe
Eun Kyung Choe
KPKyu Joo Park
Kyu Joo Park
Shin N, et al. Ann Surg Treat Res. 2020 Aug;99(2):82-89. https://doi.org/10.4174/astr.2020.99.2.82